New CRS control tests: development and validation by EUFOREA.

IF 5.7 2区医学 Q1 OTORHINOLARYNGOLOGY

Rhinology Pub Date : 2026-10-10 DOI:10.4193/Rhin26.139

D M Conti, W J Fokkens, G K Scadding, V Backer, S Lau, X Bertels, K Aanaes, M P Aguilera Quezada, A Alani, I Alobid, E Anisman, Y Chan, J Constantinidis, M Corbò, M Cornet, E J Correa, L M D Auria, E de Corso, A Del Cuvillo, M Doulaptsi, A García-Lliberós, F García Río, P Gevaert, J Han, J Lee, K Limage, G Liva, D R Lobo, A Manole, F Manole, F Mariño-Sanchez, J Maza-Solano, C Montuori, R Moreno-Luna, X I Mota Rojas, G B Patel, A Peters, E Prokopakis, S Quirce, D Ramdhani, S Reitsma, A Sánchez Barrueco, A Santamaría-Gadea, S Sánchez Gómez, T Sarafidou, S Snoeks, W Thorley, E Toskala, M Tucciarone, G Verstappen, J M Villacampa Aubá, I M Villarreal Patiño, M Wagenmann, L M Wang, C Almansa, A B Gandhi, S D Nash, A Radwan, Z Wang, A Belmans, P W Hellings

{"title":"New CRS control tests: development and validation by EUFOREA.","authors":"D M Conti, W J Fokkens, G K Scadding, V Backer, S Lau, X Bertels, K Aanaes, M P Aguilera Quezada, A Alani, I Alobid, E Anisman, Y Chan, J Constantinidis, M Corbò, M Cornet, E J Correa, L M D Auria, E de Corso, A Del Cuvillo, M Doulaptsi, A García-Lliberós, F García Río, P Gevaert, J Han, J Lee, K Limage, G Liva, D R Lobo, A Manole, F Manole, F Mariño-Sanchez, J Maza-Solano, C Montuori, R Moreno-Luna, X I Mota Rojas, G B Patel, A Peters, E Prokopakis, S Quirce, D Ramdhani, S Reitsma, A Sánchez Barrueco, A Santamaría-Gadea, S Sánchez Gómez, T Sarafidou, S Snoeks, W Thorley, E Toskala, M Tucciarone, G Verstappen, J M Villacampa Aubá, I M Villarreal Patiño, M Wagenmann, L M Wang, C Almansa, A B Gandhi, S D Nash, A Radwan, Z Wang, A Belmans, P W Hellings","doi":"10.4193/Rhin26.139","DOIUrl":null,"url":null,"abstract":"Background: Measuring control in Chronic Rhinosinusitis (CRS) is important in clinical evaluation. We developed and validated 2 new tests for the evaluation of control in CRS, the 6-item CRS Control Test (CCT) and the 14-item CRS Patient Control Test (CPCT) and investigated their correlations with existing tools.Methods: An international survey was conducted in 1,102 CRS patients in 19 centres in 7 countries using a questionnaire including the newly developed CCT and CPCT, VAS scores for CRS severity and control, the EPOS control test (EPOSCT), the Sino-Nasal Outcome Test 22 (SNOT-22) and the Patient Global Assessment Tool (PGAT). We evaluated convergent and discriminative validity, internal consistency and cross-cultural validity. Furthermore, we performed an Item Response Theory (IRT) analysis and determined cut-off points for CCT and CPCT. Sub-analyses were performed for CRS patients with and without nasal polyps.Results: Both CCT (0-24) and CPCT (0-56) demonstrated a high correlation with SNOT-22 and the PGAT. Moderate correlations were observed for all other comparisons. Both tests showed good internal consistency, discriminative validity and cross-cultural validity. We propose for CCT ≤15 to indicate uncontrolled, 16-19 partially controlled, and ≥20 well controlled disease. For the CPCT we propose ≥22 for uncontrolled, 13-21 for partially controlled and ≤12 for well controlled disease.Conclusion: The brief CCT and the longer CPCT are new CRS control tests that show moderate to high correlations with existing tools. Both instruments demonstrated good psychometric properties and therefore can be recommended for use in clinical practice and research.","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rhinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4193/Rhin26.139","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Measuring control in Chronic Rhinosinusitis (CRS) is important in clinical evaluation. We developed and validated 2 new tests for the evaluation of control in CRS, the 6-item CRS Control Test (CCT) and the 14-item CRS Patient Control Test (CPCT) and investigated their correlations with existing tools.

Methods: An international survey was conducted in 1,102 CRS patients in 19 centres in 7 countries using a questionnaire including the newly developed CCT and CPCT, VAS scores for CRS severity and control, the EPOS control test (EPOSCT), the Sino-Nasal Outcome Test 22 (SNOT-22) and the Patient Global Assessment Tool (PGAT). We evaluated convergent and discriminative validity, internal consistency and cross-cultural validity. Furthermore, we performed an Item Response Theory (IRT) analysis and determined cut-off points for CCT and CPCT. Sub-analyses were performed for CRS patients with and without nasal polyps.

Results: Both CCT (0-24) and CPCT (0-56) demonstrated a high correlation with SNOT-22 and the PGAT. Moderate correlations were observed for all other comparisons. Both tests showed good internal consistency, discriminative validity and cross-cultural validity. We propose for CCT ≤15 to indicate uncontrolled, 16-19 partially controlled, and ≥20 well controlled disease. For the CPCT we propose ≥22 for uncontrolled, 13-21 for partially controlled and ≤12 for well controlled disease.

Conclusion: The brief CCT and the longer CPCT are new CRS control tests that show moderate to high correlations with existing tools. Both instruments demonstrated good psychometric properties and therefore can be recommended for use in clinical practice and research.

查看原文本刊更多论文

新的CRS控制测试：由EUFOREA开发和验证。

背景：慢性鼻窦炎（CRS）患者的控制测量在临床评价中具有重要意义。我们开发并验证了两种评估CRS控制的新测试，即6项CRS控制测试（CCT）和14项CRS患者控制测试（CPCT），并研究了它们与现有工具的相关性。方法：对7个国家19个中心的1102例CRS患者进行国际调查，问卷包括新开发的CCT和CPCT， CRS严重程度和控制的VAS评分，EPOS控制测试（EPOSCT），鼻-鼻结果测试22 （SNOT-22）和患者整体评估工具（PGAT）。我们评估了收敛效度和判别效度、内部一致性和跨文化效度。此外，我们进行了项目反应理论（IRT）分析，并确定了CCT和CPCT的分界点。对伴有和不伴有鼻息肉的CRS患者进行亚组分析。结果：CCT（0-24）和CPCT（0-56）均与SNOT-22和pgaat高度相关。所有其他比较均观察到中度相关性。两项检验均具有良好的内部一致性、判别效度和跨文化效度。我们建议CCT≤15表示未控制，16-19表示部分控制，≥20表示控制良好。对于CPCT，我们建议不受控制的≥22，部分控制的13-21，控制良好的≤12。结论：简短CCT和较长的CPCT是新的CRS对照试验，与现有工具具有中等至高度的相关性。这两种仪器都表现出良好的心理测量特性，因此可以推荐用于临床实践和研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Rhinology 医学-耳鼻喉科学

CiteScore

15.80

自引率

9.70%

发文量

135

审稿时长

6-12 weeks

期刊介绍： Rhinology serves as the official Journal of the International Rhinologic Society and is recognized as one of the journals of the European Rhinologic Society. It offers a prominent platform for disseminating rhinologic research, reviews, position papers, task force reports, and guidelines to an international scientific audience. The journal also boasts the prestigious European Position Paper in Rhinosinusitis (EPOS), a highly influential publication first released in 2005 and subsequently updated in 2007, 2012, and most recently in 2020. Employing a double-blind peer review system, Rhinology welcomes original articles, review articles, and letters to the editor.